🔎 Trials Near Me

Dachaigh › Fàilligeadh a' Chridhe › Missouri

Sgrùdaidhean clionaigeach Fàilligeadh a' Chridhe ann an Missouri

Tha 40 sgrùdaidhean airson Fàilligeadh a' Chridhe a’ lorg phàirtichean aig làraichean ann an Missouri.

Bailtean ann an Missouri

Teacsa sgrùdaidh oifigeil (Beurla)

ELEVATE-HFpEF Clinical Study

  • Saint Lukes Mid America Heart Institute, Kansas City
A’ fastadh
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06678841

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

  • Research Site, Columbia
  • Research Site, Kansas City
  • Research Site, Kansas City
A’ fastadhÌre 3
Aoisean 18 gu 130 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06307652

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

  • Kansas City VA Medical Center, Kansas City
  • St. Louis Heart and Vascular, P.C., St Louis
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06935370

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

  • Kansas City VA Medical Center, Kansas City
  • North Kansas City Hospital, North Kansas City
  • St. Louis Heart and Vascular, P.C., St Louis
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06424288

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

  • Washington University School of Medicine, St Louis
A’ fastadhÌre 2
Aoisean 40 gu 84 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT06979362

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

  • Research Site, Bridgeton
  • Research Site, Kansas City
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07761117

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

  • Saint Luke's Hospital of Kansas City, Kansas City
  • Washington University Center for Advanced Medicine, St Louis
A’ fastadhÌre 3
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06736574

Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure

  • Saint Luke's Hospital of Kansas City, Kansas City
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07232030

A Study of LY3971297 in Participants With Heart Failure

  • Washington University, St Louis
A’ fastadhÌre 1
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07547540

Alleviant ALLAY-HFrEF Study

  • Washington University - St Louis, St Louis
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT06812533

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • Saint Luke's Hospital of Kansas City, Kansas City
A’ fastadhÌre 3
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07037459

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

  • Research Site, Columbia
  • Research Site, Kansas City
  • Research Site, Kansas City
  • agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT06677060

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

  • CON-10002 Kansas City, MO Investigative Site, Kansas City
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT06024746

The WiSE®-UP Study (The WiSE System Utilization & Performance Study)

  • St. Luke's Hospital of Kansas City, Kansas City
A’ fastadhSgrùdadh amharc
Aoisean 22 agus nas sine · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT07098858

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

  • Kansas City, MO Investigative Site 10002, Kansas City
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT06008197

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

  • WashU Medicine, St Louis
A’ fastadh
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06310031

A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)

  • Local Institution - 145, Kansas City
  • Local Institution - 109, St Louis
A’ fastadhÌre 2
Aoisean 30 gu 84 · Gach gnè · Air ùrachadh 31 Lùna 2026 · NCT07795814

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

  • Washington University-Pediatric Cardiology/ St. Louis Children's Hospital ( Site 0006), St Louis
A’ fastadhÌre 2/3
29 Days – 17 Years · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT05714085

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

  • Washington University Center for Advanced Medicine, St Louis
A’ fastadhÌre 2
Aoisean 40 gu 85 · Gach gnè · Air ùrachadh 27 Lùna 2026 · NCT06793371

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

  • Columbia
  • Kansas City
  • St Louis
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT00271180

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

  • St. Luke's Mid-America Heart Institute, Kansas City
  • Washington University, St Louis
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT05489705

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

  • Tenax Investigational Site, Kansas City
  • Tenax Investigational Site, St Louis
A’ fastadhÌre 3
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT07288398

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • Clinical Research Consultants, JCCT Co, Kansas City
  • Washington University, St Louis
  • Amicis Centers of Clinical Research, St Louis
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT07567001

Alleviant ALLAY-HF Study

  • Washington University - St Louis, St Louis
A’ fastadh
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 14 Lùna 2026 · NCT05685303

Assessment of CCM in HF With Higher Ejection Fraction

  • St. Louis Heart and Vascular, Bridgeton
  • St. Lukes Hospital Kansas City (Mid America Heart Institute), Kansas City
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT05064709

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

  • Washington Univ School Of Medicine, St Louis
A’ fastadhÌre 3
Aoisean 2 gu 11 · Gach gnè · Air ùrachadh 24 Iuch 2026 · NCT06597006

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

  • FIN-10002 Kansas City, MO Investigational Site, Kansas City
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Iuch 2026 · NCT06033950

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

  • Children's Mercy Hospital Kansas City - Cardiology, Kansas City
  • Washington University - St. Louis Children's Hospital - Cardiology, St Louis
A’ fastadhÌre 3
Suas gu aois 18 · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT07192952

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

  • St. Lukes/ Mid-American Heart Institute, Kansas City
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT05934487

A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction

  • Children's Mercy Hospital Kansas City - Cardiology, Kansas City
  • Washington University - St. Louis Children's Hospital - Cardiology, St Louis
A’ fastadhÌre 3
6 Months – 17 Years · Gach gnè · Air ùrachadh 15 Ògmh 2026 · NCT07188805

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

  • St. Luke's Hospital, Kansas City
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Ògmh 2026 · NCT06526195

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

  • University of Missouri-Columbia, Columbia
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 7 Cèit 2026 · NCT07083557

The Inorganic Nitrate and eXercise Performance in Heart Failure (iNIX-HF)

  • Washington University School of Medicine, St Louis
A’ fastadhÌre 2
Aoisean 19 gu 79 · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT05562167

CCM OPEN HF Registry

  • Saint Luke's Hospital Mid America Heart Institute, Kansas City
  • Saint Luke's Hospital of Kansas City, Kansas City
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Gibl 2026 · NCT07112924

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

  • St. Louis Heart and Vascular, St Louis
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Gibl 2026 · NCT03142152

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  • Washington University, St Louis
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 24 Màrt 2026 · NCT06217302

XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

  • Washington University - Barnes Jewish Health Hospital, St Louis
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Màrt 2026 · NCT06895070

Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator

  • University of Mossouri, Columbia
A’ fastadhÌre 4
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2025 · NCT06964464

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

  • Saint Luke's Health System, Kansas City
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 22 Cèit 2024 · NCT06425848

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

  • Washington University in Saint Louis, St Louis
A’ fastadhÌre 1/2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 26 Màrt 2024 · NCT04703842

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.